Cancer vaccine 1 article

Neoantigen vaccine design helps define cancer vaccine as a tumor-antigen immunotherapy modality with a bounded biological or analytical function. Its scientific boundary is set by neoantigen vaccine design, tumor-associated antigen targeting and personalized cancer vaccines, while dendritic cell vaccine approaches identifies one research or clinical setting in which the concept is encountered. Cancer vaccines present or encode tumor-associated antigens to shape immunity and are distinct from oncolytic viruses that use replicating or tumor-selective viral biology.